Brief: AnaptysBio Q2 Net Income USD -46.66 Million
05/08/2024 21:15
Aug 05 (Reuters) - AnaptysBio Q2 collaboration revenue USD 10.971 million. * Q2 operating expenses USD 51.292 million * Q2 income from operations USD -40.321 million
Recent news on AnaptysBio
See all newsU.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
AnaptysBio's Q1 collaboration revenue falls, net loss widens
Brief: AnaptysBio Q1 Net Income USD -52.884 Million
Brief: Anaptys Appoints Chris Murphy As Chief Financial Officer And Owen Hughes To Board Of Directors
Brief: GSK Says Unit Tesaro's Claim For Declaratory Judgment Against Anaptysbio Unchanged